Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Residual Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05704530
What this trial is testing

Liquid Biopsies in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Universitaire Ziekenhuizen KU Leuven 248
Large-scale testing (Phase 3)Study completedNCT04058353
What this trial is testing

VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 271
Not applicableStudy completedNCT01078337
What this trial is testing

T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

Who this might be right for
Leukemia, Lymphocytic, Acute
Stanford University 15
Testing effectiveness (Phase 2)Looking for participantsNCT07185165
What this trial is testing

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

Who this might be right for
Prostate Carcinoma
Jonsson Comprehensive Cancer Center 81
Not applicableEnded earlyNCT03549351
What this trial is testing

Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival

Who this might be right for
Leukemia, Myeloid, Acute
University Hospital Heidelberg 51
Not applicableStudy completedNCT01498302
What this trial is testing

Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 10
Not applicableStudy completedNCT01126827
What this trial is testing

Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder

Who this might be right for
Bipolar Disorder
Massachusetts General Hospital 46
Early research (Phase 1)WithdrawnNCT02786485
What this trial is testing

Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT

Who this might be right for
LeukemiaMyelodysplastic SyndromesLymphomas+2 more
Bellicum Pharmaceuticals
Not applicableLooking for participantsNCT04707885
What this trial is testing

Clinical Utility of Residual Hearing in the Cochlear Implant Ear

Who this might be right for
Hearing Loss, SensorineuralHearing LossHearing Loss, Bilateral
Ohio State University 40
Not applicableStudy completedNCT07360262
What this trial is testing

Gastric Emptying Recovery After GLP-1 RA Cessation

Who this might be right for
Gastric EmptyingGastroparesisPreoperative Care
Wonkwang University Hospital 186
Not applicableLooking for participantsNCT06754995
What this trial is testing

Diagnostic Feasibility of 100 Hz Tetanic Stimulation

Who this might be right for
Polyneuropathies
University of Debrecen 40
Not applicableLooking for participantsNCT06693830
What this trial is testing

CtDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Who this might be right for
LymphomaLymphoma, B-CellDiffuse Large B Cell Lymphoma+2 more
Hua-Jay J Cherng, MD 40
Early research (Phase 1)Active Not RecruitingNCT06358430
What this trial is testing

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

Who this might be right for
Colorectal CancerMinimal Residual Disease
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06426511
What this trial is testing

CtDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC

Who this might be right for
Lung Cancer, Nonsmall Cell
Sun Yat-sen University 80
Not applicableEnded earlyNCT04031911
What this trial is testing

Study of the Benefits of a Short Spa Treatment on the Elimination of Residual Lithic Fragments After Treatment

Who this might be right for
Calculi, Urinary
GUILLEMIN Francis, MD 1
Testing effectiveness (Phase 2)Looking for participantsNCT06088381
What this trial is testing

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaOropharynx Cancer+2 more
University of Maryland, Baltimore 61
Not applicableStudy completedNCT06525116
What this trial is testing

MRD Detection by NGS in Pediatric T-ALL

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
The Children's Hospital of Zhejiang University School of Medicine 148
Not applicableLooking for participantsNCT07724171
What this trial is testing

Long-term Outcomes After Percutaneous Patent Foramen Ovale Closure (Severance PFO Registry)

Who this might be right for
Patent Foramen OvaleCryptogenic StrokeTransient Ischemic Attack Due to Embolism+1 more
Yonsei University 400
Not applicableLooking for participantsNCT07214532
What this trial is testing

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastReceptors, Estrogen (for ER-positive Requirement)
Natera, Inc. 725
Not applicableUnknownNCT05827029
What this trial is testing

Gastric Volume After Ingestion of Carbohydrate Drink vs Water in Obese Volunteers

Who this might be right for
ObesityGastric Emptying
Prince of Songkla University 30
Next Page